Evinova:
Your Partner in Cancer Research

Innovation in oncology research is creating new opportunities and complexities for clinical trials. Evinova’s solutions empower oncology researchers to improve outcomes and elevate the clinical trial experience for both sites and patients.

Experience matters:

A Seasoned Team of Oncology Experts

Built by pharma for pharma, Evinova understands the intricate nature of running global cancer studies from the inside. Our teams of experienced scientists and strategists collaborate with industry-leading oncology partners to develop fit-for-purpose solutions, designed to maximize trial success and accelerate breakthroughs in cancer treatment.

“It’s an exciting time to work in cancer research, but new modalities and approaches bring new questions as well about safety, efficacy and patient experience. At Evinova, we know first-hand the pressures that teams are under to deliver an effective and differentiated cancer medicine. We’re ready to partner with you to design the right digital strategy and collect the right data to support your desired outcomes.”

Man smiling

Luis Garcia-Gancedo PhD MBA

Head of Digital Health Strategy, Oncology Therapy Area

Fit-For-Purpose Digital Solutions for Oncology Clinical Trials

Toxicity is unpredictable. Treatment-related symptoms can present suddenly and escalate rapidly, regardless of where the patient is in their treatment. Without intensive in-patient monitoring, clinicians lack visibility over symptom onset andevolution, which can result in dose reduction, treatment interruption or discontinuation, and severe impacts to patients’ health.

Evinova's remote patient monitoring (RPM) via our Unified Trial Solution enables real-time, data-driven management of treatment toxicities, accelerating clinical intervention and potentially keeping patients on therapeutic dose for longer to achieve better outcomes.

A lab with scientists

Center data collection around the patient

Monitor patient safety and symptoms in real-time

Accelerate clinical intervention at toxicity onset to drive better health outcomes

Deliver data to support novel digital endpoints for treatment tolerability

Better understanding of exposure-response relationships for dose optimization decisions

GI, stomatitis and pulmonary RPM modules available today, with dermatological, cytokine release syndrome, ocular and pain/neutropenia in development

Having cancer is hard – participating in a clinical trial shouldn’t make it harder. Evinova’s Unified Trial Solution is designed to remove complexity and reduce burden at every step via an integrated app that serves as a single destination for all study conduct activities.

Woman sitting looking at her phone

eCOA/PRO completion, with an eCOA library of 100+ pre-configured assessments

Visit management, virtual or in person

Medication reminders

Direct feedback through coping tips and other configurable notifications

Direct link to HCP through in app telehealth, deep link to call function

Singular experience for all connected devices in app to simplify patient experience

Critical study level info including training, study info, site contact details

Unified Trial Solution enables 70% of critical assessments, such as blood pressure, pulse ox and respiratory rate, to be completed at home, reducing patient travel, time commitment and expenses.

When it comes to delivering the cancer treatments of tomorrow, speed matters. Evinova’s Study Design and Planning is a unified platform that helps teams to confidently design and set up innovative studies with a positive site and patient experience that efficiently deliver data to support regulatory and market access goals.

A microscope

Design studies with the power of data and AI to accelerate productivity and outcomes

Easily optimize studies across design levers including cost, complexity, experience, speed and carbon emissions

Industry-leading cost estimation with ​97%+ accuracy

Effortlessly compare options and scenarios to accelerate decision making

Transform your clinical trials today

Contact Us